Monro-Kellie 4.0 Redefines Brain Pressure Management Beyond ICP Numbers

The Monro-Kellie Doctrine, first articulated in the late 18th century, has long served as the foundational framework for understanding how the brain, blood, and cerebrospinal fluid (CSF) coexist within the skull's rigid vault. The original principle — that an increase in one intracranial component must be offset by a decrease in another to maintain stable ICP — has been progressively refined over centuries. This 2025 review in Critical Care traces that evolution through four iterative versions and proposes Monro-Kellie 4.0 as a paradigm shift from pressure-centric to dynamics-centric neurocritical care.

The authors outline the progression systematically. MK 1.0 (classical doctrine) established the fixed-volume constraint. MK 2.0 (2016) incorporated extracranial influences — particularly intrathoracic and intra-abdominal pressures transmitted via venous and CSF pathways — recognizing that venous congestion can raise ICP even without intracranial pathology. MK 3.0 (2019) acknowledged that elastic brain tissue remodeling, as seen in idiopathic intracranial hypertension and normal pressure hydrocephalus, can cause structural damage and periventricular fiber distension without classic ICP elevation. MK 4.0 now centers on three dynamic systems: cerebrovascular autoregulation (CA), glymphatic system function, and intracranial compensatory reserve.

A central argument of MK 4.0 concerns the unreliability of CPP as calculated by subtracting ICP from arterial blood pressure (ABP). The review details how mean ABP can drop 10–15 mmHg between the heart and the skull base, and arterial pressure within cerebral microvasculature may fall to as little as half of aortic pressure. This means that the same calculated CPP (e.g., 60 mmHg) can represent very different states of actual tissue perfusion depending on the underlying combination of ABP and ICP values. When CA is impaired — which occurs in proportion to injury severity — even modest ICP elevations of approximately 5 mmHg can reduce cerebral blood velocity for longer durations than equivalent ABP changes, and vessel transmural pressure (resistance-area product) remains elevated even after decompressive craniectomy.

The review introduces the concept of Intracranial Compartment Syndrome (ICS) as a more clinically actionable framework. ICS describes patients with exhausted intracranial compliance and brain hypoxia whose ICP remains below the traditional intervention threshold of 20–22 mmHg. The authors argue that waiting for ICP to breach this threshold before escalating treatment has contributed to the perception that management of moderate-to-severe TBI is futile. ICS-oriented monitoring instead prioritizes ICP-derived waveform parameters — including the P2/P1 ratio, time-to-peak, pulse shape index, RAP index, and ICP pulse amplitude — which have demonstrated stronger correlations with patient outcomes than absolute ICP values alone.

For clinical implementation, the review highlights that the optimal individualized CPP (CPPopt) — the ABP range at which ICP is most stable, calculated via the pressure-reactivity index using ICM+ software — is currently the only validated continuous method for personalizing perfusion targets. Studies show that the longer patients remain outside their CPPopt range, the higher the mortality rate. The critical lower limit of CA, commonly cited as 50 mmHg, may actually be closer to 70 mmHg based on a review of multiple studies. The authors call for next-generation noninvasive, point-of-care tools — including transcranial Doppler-based CPP estimation, automated pupillometry, and noninvasive ICP waveform monitoring — to make personalized intracranial dynamics assessment broadly accessible, including in low-resource settings.